Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 26, 2024 -- Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network Open.
Erikka Loftfield, Ph.D., M.P.H., from the National Institutes of Health in Rockville, Maryland, and colleagues estimated the association of MV use with mortality risk, accounting for confounding by healthy lifestyle and reverse causation. The cohort study used data from three U.S. prospective cohort studies, each with baseline MV use assessed from 1993 to 2001 and follow-up MV use assessed from 1998 to 2004; follow-up was for up to 27 years.
Data were included for 390,124 adults; during follow-up, there were 164,762 deaths. The researchers found that 49.3 and 42.0 percent of daily MV users were female and college educated, respectively, compared with 39.3 and 37.9 percent among nonusers. Overall, 11.0 and 13.0 percent of daily users and nonusers, respectively, were current smokers. There was no association observed for MV use with lower all-cause mortality risk in the first or second halves of follow-up. For major causes of death and time-varying analyses, hazard ratios were similar.
"We did not find evidence to support improved longevity among healthy adults who regularly take multivitamins," the authors write. "However, we cannot preclude the possibility that daily MV use may be associated with other health outcomes related to aging."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
Vitamin D Suggested for Children, Seniors, Those With High-Risk Prediabetes
MONDAY, June 10, 2024 -- Empiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk...
Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women
FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.